The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children

被引:188
作者
Mofenson, LM
Korelitz, J
Meyer, WA
Bethel, J
Rich, K
Pahwa, S
Moye, J
Nugent, R
Read, J
机构
[1] QUEST DIAGNOST INC,BALTIMORE,MD
[2] UNIV ILLINOIS,SCH MED,CHICAGO,IL
[3] WESTAT CORP,ROCKVILLE,MD
[4] N SHORE UNIV HOSP,MANHASSET,NY
关键词
D O I
10.1086/516441
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Association of human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 cell percent, and mortality was examined in stored sera from 254 infected children in an intravenous immunoglobulin infection prophylaxis trial, Ninety-two children (36.2%) died (41 during the study, 51 during longterm follow-up), The geometric mean baseline HIV-1 RNA level was 104,626 copies/mL, and the mean CD4 cell percent was 25%, Relative risk of death (RR) was 2.1 if the baseline RNA level was > 100,000 copies/mL (95% confidence interval [CI], 1.4-3.0) and was 3.0 if the baseline CD4 cell percent was < 15% (95% CI, 2.2-4.0), If RNA levels increased after baseline, the RR was 1.8 (95% CI, 1.3-2.6), and if the CD4 cell percent dropped to < 15%, the RR was 2.8 (95% CI, 1.6-4.9). In a multivariate model, both baseline RNA level and CD4 cell percent were independently associated with mortality risk. In a time-dependent model, the RR per log(10) increase in HIV-1 RNA copy numbers was 2.8 (95% CI, 2.1-3.6) and per 5 percentage point decrement in CD4 cell percent was 1.3 (95% CI, 1.2-1.5), Both variables should be considered for in decision-making regarding therapy and evaluation of antiretroviral response.
引用
收藏
页码:1029 / 1038
页数:10
相关论文
共 24 条
[1]  
Abrams Elaine, 1996, P25
[2]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[3]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[4]   Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection [J].
Clementi, M ;
Menzo, S ;
Bagnarelli, P ;
Valenza, A ;
Paolucci, S ;
Sampaolesi, R ;
Manzin, A ;
Varaldo, PE .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :135-+
[5]   Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection [J].
DeRossi, A ;
Masiero, S ;
Giaquinto, C ;
Ruga, E ;
Comar, M ;
Giacca, M ;
ChiecoBianchi, L .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :323-330
[6]   Viral dynamics of HIV: Implications for drug development and therapeutic strategies [J].
Havlir, DV ;
Richman, DD .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :984-994
[7]  
HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554
[8]   Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection a mathematical model [J].
Ioannidis, JPA ;
Cappelleri, JC ;
Lau, J ;
Sacks, HS ;
Skolnik, PR .
AIDS, 1996, 10 (03) :255-262
[9]   THE NATURAL-HISTORY OF HIV-1 INFECTION - VIRUS LOAD AND VIRUS PHENOTYPE INDEPENDENT DETERMINANTS OF CLINICAL COURSE [J].
JURRIAANS, S ;
VANGEMEN, B ;
WEVERLING, GJ ;
VANSTRIJP, D ;
NARA, P ;
COUTINHO, R ;
KOOT, M ;
SCHUITEMAKER, H ;
GOUDSMIT, J .
VIROLOGY, 1994, 204 (01) :223-233
[10]   The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter [J].
Katzenstein, DA ;
Hammer, SM ;
Hughes, MD ;
Gundacker, H ;
Jackson, JB ;
Fiscus, S ;
Rasheed, S ;
Elbeik, T ;
Reichman, R ;
Japour, A ;
Merigan, TC ;
Hirsch, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1091-1098